Maintenance of sinus rhythm after cardioversion of atrial fibrillation in patients with lone atrial fibrillation and patients with hypertension

Annals of Noninvasive Electrocardiology

Volumn 3, Issue 2, 1998, Pages 103-108

  Carlsson, Joerg ^a   Appel, Karl Friedrich ^a   Von Essen, Rainer ^a   Jansen, Wolfgang ^a   Miketic, Sinisa ^a   Stammwitz, Ekkehard ^a   Kettner, Wolfgang ^a   Tebbe, Ulrich ^a  

^a KLINIKUM LIPPE DETMOLD   (Germany)

Author keywords

Atrial fibrillation; Cardioversion; Hypertension; Lone atrial fibrillation

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; CORDICHIN; FLECAINIDE; PROPAFENONE; QUINIDINE; UNCLASSIFIED DRUG; VERAPAMIL;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL TRIAL; DISEASE DURATION; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; SINUS RHYTHM;

EID: 0031925240     PISSN: 1082720X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1542-474x.1998.tb00405.x     Document Type: Article

References (18)

1. Lie KI, Crijns HJGM, van Gelder 1C. Pharmacological treatment of atrial fibrillation. Chapter in HE Kulbertus, HJJ Wellens, IMGP Bourgeois, et al. (eds): Atrial Fibrillation: Facts From Yesterday, Ideas for Tomorrow. Futura Publishing Company Inc., Armonk, NY, 1994, pp. 111-124.
2. Golzari H, Cebul RD, Bahler RC. Atrial fibrillation: Restoration and maintenance of sinus rhythm and indications for anticoagulation therapy. Ann Intern Med 1996; 125:311323.
3. Carlsson J, Tebbe U, Rox J, et al. Cardioversion of atrial fibrillation in the elderly. Am J Cardiol 1996; 78:1380-1384.
4. Kopecky SL, Gersh BJ, McGoon MD, et al. The natural history of lone atrial fibrillation: A population-based study over three decades. N Engl J Med 1987; 317:669-674.
5. Brand FN, Abbott RD, Kännel WB, et al. Characteristics and prognosis of lone atrial fibrillation: 30-year follow-up in the Framingham Study. JAMA 1985;254:3449-3453.
6. Murgatroyd FD, Camm AJ. Atrial arrhythmias. Lancet 1993;341:1317-1322.
7. Karlson BW, Torstensson I, Abjoern C, et al. Disopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation. A placebo-controlled one-year followup study. Eur Heart J 1988;9:284-290.
8. Juul-Moeller S, Edvardsson N, Rehnqvist-Ahlberg N. Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation. Circulation 1990; 82:1932-1939.
9. Van Gelder 1C, Crijns HJ, Van Gilst WH, et al. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 1991;68:41-46.
10. Brodsky MA, Alien BJ, Capparelli EV, et al. Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation. Am J Cardiol 1989; 63: 1065-1068.
11. Reimold SC, Lamas GA, Cantillon CO, et al. Risk factors for the development of recurrent atrial fibrillation: Role of pacing and clinical variables. Am Heart J 1995; 129:11271132.
12. Arnar DO, Danielsen R. Factors predicting maintenance of sinus rhythm after direct current cardioversion of atrial fibrillation and flutter: A reanalysis with recently acquired data. Cardiology 1996;87:181-188.
13. Dittrich HC, Erickson JS, Schneidermann T, et al. Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol 1989; 63: 193-197.
14. Suttorp MJ, Kingma JH, Koomen EM, et al. Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. Am J Cardiol 1993;71:710-713.
15. The National Heart, Lung, and Blood Institute Working Group on Atrial Fibrillation. Atrial fibrillation. Current understandings and research imperatives. J Am Coll Cardiol 1993;22:1830-1834.
16. McCrory DC, Matchar DB, Samsa G, et al. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med 1995; 155:277-281.
17. Lip GYH, Zarifis J, Watson RDS, et al. Physicians variation in the management of patients with atrial fibrillation. Heart 1996; 75:200-205.
18. Laupacis A, Albers G, Dalen J, et al. Antithrombotic therapy in atrial fibrillation. (Third American College of Chest Physicians' Consensus Conference on Antithrombotic Therapy). Chest 1995;108(suppl):352S-359S.